Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US

JAMA. 2020 Nov 17;324(19):1937-1938. doi: 10.1001/jama.2020.19692.
No abstract available

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • Clinical Trials, Phase IV as Topic
  • Drug Development
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza Vaccines
  • Product Surveillance, Postmarketing*
  • Public Health Surveillance
  • United States

Substances

  • COVID-19 Vaccines
  • Influenza Vaccines